[1]AbdellatifM, SedejS, KroemerG, 2021. NAD⁺ metabolism in cardiac health, aging, and disease. Circulation, 144(22):1795-1817.

[2]AflatounianA, ParisVR, RichaniD, et al., 2022. Declining muscle NAD⁺ in a hyperandrogenism PCOS mouse model: possible role in metabolic dysregulation. Mol Metab, 65:101583.

[3]AmjadS, NisarS, BhatAA, et al., 2021. Role of NAD⁺ in regulating cellular and metabolic signaling pathways. Mol Metab, 49:101195.

[4]BaiP, CantoC, BrunyánszkiA, et al., 2011a. PARP-2 regulates SIRT1 expression and whole-body energy expenditure. Cell Metab, 13(4):450-460.

[5]BaiP, CantoC, OudartH, et al., 2011b. PARP-1 inhibition increases mitochondrial metabolism through SIRT1 activation. Cell Metab, 13(4):461-468.

[6]BelenkyP, BoganKL, BrennerC, 2007. NAD⁺ metabolism in health and disease. Trends Biochem Sci, 32(1):12-19.

[7]BertoldoMJ, ListijonoDR, HoWHJ, et al., 2020. NAD⁺ repletion rescues female fertility during reproductive aging. Cell Rep, 30(6):1670-1681.e7.

[8]BritoS, BaekJM, ChaB, et al., 2022. Nicotinamide mononucleotide reduces melanin production in aged melanocytes by inhibiting cAMP/Wnt signaling. J Dermatol Sci, 106(3):159-169.

[9]Camacho-PereiraJ, TarragoMG, ChiniCCS, et al., 2016. CD38 dictates age-related NAD decline and mitochondrial dysfunction through an SIRT3-dependent mechanism. Cell Metab, 23(6):1127-1139.

[10]ChalkiadakiA, GuarenteL, 2015. The multifaceted functions of sirtuins in cancer. Nat Rev Cancer, 15(10):608-624.

[11]ChenXH, AmorimJA, MoustafaGA, et al., 2020. Neuroprotective effects and mechanisms of action of nicotinamide mononucleotide (NMN) in a photoreceptor degenerative model of retinal detachment. Aging, 12(24):24504-24521.

[12]ChiniCCS, PeclatTR, WarnerGM, et al., 2020. CD38 ecto-enzyme in immune cells is induced during aging and regulates NAD⁺ and NMN levels. Nat Metab, 2(11):1284-1304.

[13]CohenMS, 2020. Interplay between compartmentalized NAD⁺ synthesis and consumption: a focus on the PARP family. Genes Dev, 34(5-6):254-262.

[14]CovarrubiasAJ, PerroneR, GrozioA, et al., 2021. NAD⁺ metabolism and its roles in cellular processes during ageing. Nat Rev Mol Cell Biol, 22(2):119-141.

[15]CrosC, MargierM, CannelleH, et al., 2022. Nicotinamide mononucleotide administration triggers macrophages reprogramming and alleviates inflammation during sepsis induced by experimental peritonitis. Front Mol Biosci, 9:895028.

[16]de VosM, SchreiberV, DantzerF, 2012. The diverse roles and clinical relevance of PARPs in DNA damage repair: current state of the art. Biochem Pharmacol, 84(2):137-146.

[17]di StefanoM, Nascimento-FerreiraI, OrsomandoG, et al., 2015. A rise in NAD precursor nicotinamide mononucleotide (NMN) after injury promotes axon degeneration. Cell Death Differ, 22(5):731-742.

[18]FangEF, Scheibye-KnudsenM, BraceLE, et al., 2014. Defective mitophagy in XPA via PARP-1 hyperactivation and NAD⁺/SIRT1 reduction. Cell, 157(4):882-896.

[19]FangEF, KassahunH, CroteauDL, et al., 2016. NAD⁺ replenishment improves lifespan and healthspan in ataxia telangiectasia models via mitophagy and DNA repair. Cell Metab, 24(4):566-581.

[20]FletcherRS, RatajczakJ, DoigCL, et al., 2017. Nicotinamide riboside kinases display redundancy in mediating nicotinamide mononucleotide and nicotinamide riboside metabolism in skeletal muscle cells. Mol Metab, 6(8):819-832.

[21]FrederickDW, LoroE, LiuL, et al., 2016. Loss of NAD homeostasis leads to progressive and reversible degeneration of skeletal muscle. Cell Metab, 24(2):269-282.

[22]GartenA, GrohmannT, KluckovaK, et al., 2019. Sorafenib-induced apoptosis in hepatocellular carcinoma is reversed by SIRT1. Int J Mol Sci, 20(16):4048.

[23]HouYJ, LautrupS, CordonnierS, et al., 2018. NAD⁺ supplementation normalizes key Alzheimer’s features and DNA damage responses in a new ad mouse model with introduced DNA repair deficiency. Proc Natl Acad Sci USA, 115(8):E1876-E1885.

[24]HsuCP, OkaS, ShaoD, et al., 2009. Nicotinamide phosphoribosyltransferase regulates cell survival through NAD⁺ synthesis in cardiac myocytes. Circ Res, 105(5):481-491.

[25]HuangP, ZhouY, TangWH, et al., 2022. Long-term treatment of Nicotinamide mononucleotide improved age-related diminished ovary reserve through enhancing the mitophagy level of granulosa cells in mice. J Nutr Biochem, 101:108911.

[26]ImaiSI, 2011. Dissecting systemic control of metabolism and aging in the NAD world: the importance of SIRT1 and NAMPT-mediated NAD biosynthesis. FEBS Lett, 585(11):1657-1662.

[27]IrieJ, InagakiE, FujitaM, et al., 2020. Effect of oral administration of nicotinamide mononucleotide on clinical parameters and nicotinamide metabolite levels in healthy Japanese men. Endocr J, 67(2):153-160.

[28]JiangY, WangD, ZhangC, et al., 2023. Nicotinamide mononucleotide restores oxidative stress-related apoptosis of oocyte exposed to benzyl butyl phthalate in mice. Cell Prolif, 56(8):e13419.

[29]JiangYF, LiuTT, LeeCH, et al., 2020. The NAD⁺-mediated self-inhibition mechanism of pro-neurodegenerative SARM1. Nature, 588(7839):658-663.

[30]KaneAE, SinclairDA, 2018. Sirtuins and NAD⁺ in the development and treatment of metabolic and cardiovascular diseases. Circ Res, 123(7):868-885.

[31]LiL, HanQ, ChenY, et al., 2023. β-nicotinamide mononucleotide rescues the quality of aged oocyte and improves subsequent embryo development in pigs. PLoS ONE, 18(10):e0291640.

[32]LuoCT, DingWX, YangCM, et al., 2022. Nicotinamide mononucleotide administration restores redox homeostasis via the Sirt3‒Nrf2 axis and protects aged mice from oxidative stress-induced liver injury. J Proteome Res, 21(7):1759-1770.

[33]MargierM, KuehnemannC, HuloN, et al., 2023. Nicotinamide mononucleotide administration prevents doxorubicin-induced cardiotoxicity and loss in physical activity in mice. Cells, 12(1):108.

[34]MengF, ZhangYN, DuJY, et al., 2024. Nicotinamide mononucleotide maintains cytoskeletal stability and fortifies mitochondrial function to mitigate oocyte damage induced by triocresyl phosphate. Ecotoxicol Environ Saf, 275:116264.

[35]MiaoYL, CuiZK, GaoQ, et al., 2020. Nicotinamide mononucleotide supplementation reverses the declining quality of maternally aged oocytes. Cell Rep, 32(5):107987.

[36]MillsKF, YoshidaS, SteinLR, et al., 2016. Long-term administration of nicotinamide mononucleotide mitigates age-associated physiological decline in mice. Cell Metab, 24(6):795-806.

[37]MonzelAS, EnríquezJA, PicardM, 2023. Multifaceted mitochondria: moving mitochondrial science beyond function and dysfunction. Nat Metab, 5(4):546-562.

[38]NomiyamaT, SetoyamaD, YasukawaT, et al., 2022. Mitochondria metabolomics reveals a role of β-nicotinamide mononucleotide metabolism in mitochondrial DNA replication. J Biochem, 171(3):325-338.

[39]OkabeK, YakuK, TobeK, et al., 2019. Implications of altered NAD metabolism in metabolic disorders. J Biomed Sci, 26:34.

[40]PalmerAK, JensenMD, 2022. Metabolic changes in aging humans: current evidence and therapeutic strategies. J Clin Invest, 132(16):e158451.

[41]Piedra-QuinteroZL, WilsonZ, NavaP, et al., 2020. CD38: an immunomodulatory molecule in inflammation and autoimmunity. Front Immunol, 11:597959.

[42]PoddarSK, SifatAE, HaqueS, et al., 2019. Nicotinamide mononucleotide: exploration of diverse therapeutic applications of a potential molecule. Biomolecules, 9:34.

[43]PuQ, GuoXX, HuJJ, et al., 2022. Nicotinamide mononucleotide increases cell viability and restores tight junctions in high-glucose-treated human corneal epithelial cells via the SIRT1/Nrf2/HO-1 pathway. Biomed Pharmacother, 147:112659.

[44]RevolloJR, KörnerA, MillsKF, et al., 2007. Nampt/PBEF/visfatin regulates insulin secretion in β cells as a systemic NAD biosynthetic enzyme. Cell Metab, 6(5):363-375.

[45]SanadaS, KomuroI, KitakazeM, 2011. Pathophysiology of myocardial reperfusion injury: preconditioning, postconditioning, and translational aspects of protective measures. Am J Physiol Heart Circ Physiol, 301(5):H1723-H1741.

[46]ShenQ, ZhangSJ, XueYZ, et al., 2021. Biological synthesis of nicotinamide mononucleotide. Biotechnol Lett, 43(12):2199-2208.

[47]SinghAK, MohantyA, KumarSL, et al., 2024. Diminished NAD+ levels and activation of retrotransposons promote postovulatory aged oocyte (POAO) death. Cell Death Discov, 10:104.

[48]SurjanaD, HallidayGM, MartinAJ, et al., 2012. Oral nicotinamide reduces actinic keratoses in phase II double-blinded randomized controlled trials. J Invest Dermatol, 132(5):1497-1500.

[49]SurjanaD, HallidayGM, DamianDL, 2013. Nicotinamide enhances repair of ultraviolet radiation-induced DNA damage in human keratinocytes and ex vivo skin. Carcinogenesis, 34(5):1144-1149.

[50]TakedaK, OkumuraK, 2021. Nicotinamide mononucleotide augments the cytotoxic activity of natural killer cells in young and elderly mice. Biomed Res, 42(5):173-179.

[51]ThompsonBC, SurjanaD, HallidayGM, et al., 2014. Nicotinamide enhances repair of ultraviolet radiation-induced DNA damage in primary melanocytes. Exp Dermatol, 23(7):509-511.

[52]TongD, SchiattarellaGG, JiangN, et al., 2021. NAD⁺ repletion reverses heart failure with preserved ejection fraction. Circ Res, 128(11):1629-1641.

[53]VermaK, JaiswalR, PaliwalS, et al., 2023. An insight into PI3K/Akt pathway and associated protein‒protein interactions in metabolic syndrome: a recent update. J Cell Biochem, 124(7):923-942.

[54]WalkerMA, TianR, 2018. Raising NAD in heart failure: time to translate? Circulation, 137(21):2274-2277.

[55]WalkerMA, ChenH, YadavA, et al., 2023. Raising NAD⁺ level stimulates short-chain dehydrogenase/reductase proteins to alleviate heart failure independent of mitochondrial protein deacetylation. Circulation, 148(25):2038-2057.

[56]WangH, SunYA, PiCC, et al., 2022. Nicotinamide mononucleotide supplementation improves mitochondrial dysfunction and rescues cellular senescence by NAD⁺/Sirt3 pathway in mesenchymal stem cells. Int J Mol Sci, 23(23):14739.

[57]WangLQ, ZhaoMY, QianR, et al., 2023. Nicotinamide mononucleotide ameliorates silica-induced lung injury through the Nrf2-regulated glutathione metabolism pathway in mice. Nutrients, 15(1):143.

[58]WangQH, LiY, DouDY, et al., 2021. Nicotinamide mononucleotide-elicited NAMPT signaling activation aggravated adjuvant-induced arthritis in rats by affecting peripheral immune cells differentiation. Int Immunopharmacol, 98:107856.

[59]WątrobaM, DudekI, SkodaM, et al., 2017. Sirtuins, epigenetics and longevity. Ageing Res Rev, 40:11-19.

[60]YooKH, TangJJ, RashidMA, et al., 2021. Nicotinamide mononucleotide prevents cisplatin-induced cognitive impairments. Cancer Res, 81(13):3727-3737.

[61]YoshinoJ, MillsKF, YoonMJ, et al., 2011. Nicotinamide mononucleotide, a key NAD⁺ intermediate, treats the pathophysiology of diet- and age-induced diabetes in mice. Cell Metab, 14(4):528-536.

[62]YoshinoM, YoshinoJ, KayserBD, et al., 2021. Nicotinamide mononucleotide increases muscle insulin sensitivity in prediabetic women. Science, 372(6547):1224-1229.

[63]YuP, MaSC, DaiXC, et al., 2020. Inhibitive effect of nicotinamide mononucleotide on angiotensin II-induced cardiac fibrosis in mice and its mechanism. Chin J Mult Organ Dis Elderly, 19(6):452-456 (in Chinese).

[64]ZhangGZ, DengYJ, XieQQ, et al., 2020. Sirtuins and intervertebral disc degeneration: roles in inflammation, oxidative stress, and mitochondrial function. Clin Chim Acta, 508:33-42.

[65]ZhangRL, ShenYY, ZhouL, et al., 2017. Short-term administration of nicotinamide mononucleotide preserves cardiac mitochondrial homeostasis and prevents heart failure. J Mol Cell Cardiol, 112:64-73.

[66]ZhaoC, LiWJ, DuanHY, et al., 2020. NAD⁺ precursors protect corneal endothelial cells from UVB-induced apoptosis. Am J Physiol Cell Physiol, 318(4):C796-C805.

[67]ZhaoYZ, LiH, GuoQL, et al., 2023. Multiple characteristic alterations and available therapeutic strategies of cellular senescence. J Zhejiang Univ-Sci B (Biomed & Biotechnol), 24(2):101-114.

[68]ZhouB, WangDDH, QiuYH, et al., 2020. Boosting NAD level suppresses inflammatory activation of PBMCs in heart failure. J Clin Invest, 130(11):6054-6063.

[69]ZhouXR, DuHH, NiLY, et al., 2021. Nicotinamide mononucleotide combined with lactobacillus fermentum TKSN041 reduces the photoaging damage in murine skin by activating AMPK signaling pathway. Front Pharmacol, 12:643089.